{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T02:54:22Z","timestamp":1720580062009},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.prp.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T17:21:19Z","timestamp":1523985679000},"page":"625-630","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The SMYD3 VNTR 3\/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population"],"prefix":"10.1016","volume":"214","author":[{"given":"Rui-Dong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2018.04.005_bib0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cam4.1341","article-title":"A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.prp.2018.04.005_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11605-015-3045-3","article-title":"Postresection outcomes of combined hepatocellular carcinoma-cholangiocarcinoma, hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"20","author":"Yoon","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"3","key":"10.1016\/j.prp.2018.04.005_bib0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jso.24123","article-title":"The importance of surgical margins in primary malignancies of the liver","volume":"113","author":"Lafaro","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2018.04.005_bib0020","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12253-015-9918-7","article-title":"Differential expression of sonic hedgehog protein in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"21","author":"Al-Bahrani","year":"2015","journal-title":"Pathol. Oncol. Res."},{"issue":"6","key":"10.1016\/j.prp.2018.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ijc.27352","article-title":"A polymorphism at the mir-502 binding site in the 3'-untranslated region of the histone methyltransferase set8 is associated with hepatocellular carcinoma outcome","volume":"131","author":"Guo","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3S","key":"10.1016\/j.prp.2018.04.005_bib0030","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.je.2016.12.007","article-title":"Characteristics of patients with liver cancer in the biobank japan project","volume":"27","author":"Ukawa","year":"2017","journal-title":"J. Epidemiol."},{"issue":"9","key":"10.1016\/j.prp.2018.04.005_bib0035","doi-asserted-by":"crossref","first-page":"e74870","DOI":"10.1371\/journal.pone.0074870","article-title":"Effects of ezh2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2018.04.005_bib0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.7314\/APJCP.2012.13.5.1895","article-title":"Liver cancer mortality trends during the last 30 years in hebei province: comparison results from provincial death surveys conducted in the 1970's, 1980's, 1990's and 2004\u20132005","volume":"13","author":"Xu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.prp.2018.04.005_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3350\/kjhep.2012.18.1.48","article-title":"Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience","volume":"18","author":"Lee","year":"2012","journal-title":"Korean J. Hepatol."},{"key":"10.1016\/j.prp.2018.04.005_bib0050","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.12659\/MSM.895548","article-title":"Improvement of survival rate for patients with hepatocellular carcinoma using transarterial chemoembolization in combination with three-dimensional conformal radiation therapy: a meta-analysis","volume":"22","author":"Bai","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.prp.2018.04.005_bib0055","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.12659\/MSM.898095","article-title":"Set and mynd domain-containing protein 3 (smyd3) polymorphism as a risk factor for susceptibility and poor prognosis in ovarian cancer","volume":"22","author":"Liu","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"18","key":"10.1016\/j.prp.2018.04.005_bib0060","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1093\/nar\/gkv874","article-title":"Cooperation between smyd3 and pc4 drives a distinct transcriptional program in cancer cells","volume":"43","author":"Kim","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.prp.2018.04.005_bib0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/0008-5472.CAN-11-1052","article-title":"Smyd3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase mmp-9","volume":"72","author":"Cock-Rada","year":"2012","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2018.04.005_bib0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.2011.35.3078","article-title":"Association of family history with cancer recurrence and survival in patients with gastric cancer","volume":"30","author":"Han","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2018.04.005_bib0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4161\/epi.19506","article-title":"Smyd3 regulates cancer cell phenotypes and catalyzes histone h4 lysine 5 methylation","volume":"7","author":"Van Aller","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.prp.2018.04.005_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2014.05.016","article-title":"The lysine methyltransferase smyd3 interacts with hepatitis c virus ns5a and is a negative regulator of viral particle production","volume":"462\u2013463","author":"Eberle","year":"2014","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.prp.2018.04.005_bib0085","first-page":"1","article-title":"Set and mynd domain containing protein 3 in cancer","volume":"9","author":"Huang","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.prp.2018.04.005_bib0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1349-7006.2010.01782.x","article-title":"Dual roles of a variable number of tandem repeat polymorphism in the tert gene in lung cancer","volume":"102","author":"Jin","year":"2011","journal-title":"Cancer Sci."},{"issue":"21","key":"10.1016\/j.prp.2018.04.005_bib0095","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v18.i21.2661","article-title":"Family history influences the early onset of hepatocellular carcinoma","volume":"18","author":"Park","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.prp.2018.04.005_bib0100","doi-asserted-by":"crossref","first-page":"e108391","DOI":"10.1371\/journal.pone.0108391","article-title":"Familial correlations of onset age of hepatocellular carcinoma: a population-based case-control family study","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2018.04.005_bib0105","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.24794","article-title":"Family history of liver cancer and hepatocellular carcinoma","volume":"55","author":"Turati","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.prp.2018.04.005_bib0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1008989103809","article-title":"A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in north italy. Brescia hcc study","volume":"10","author":"Donato","year":"1999","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.prp.2018.04.005_bib0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7314\/APJCP.2012.13.3.743","article-title":"Risk factors of hepatocellular carcinoma\u2013current status and perspectives","volume":"13","author":"Gao","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.prp.2018.04.005_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12072-013-9494-4","article-title":"Mechanisms of alcohol-induced hepatocellular carcinoma","volume":"8","author":"Sidharthan","year":"2014","journal-title":"Hepatol. Int."},{"issue":"10","key":"10.1016\/j.prp.2018.04.005_bib0125","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/jcp.24975","article-title":"A smyd3 small-molecule inhibitor impairing cancer cell growth","volume":"230","author":"Peserico","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.prp.2018.04.005_bib0130","doi-asserted-by":"crossref","first-page":"e22290","DOI":"10.1371\/journal.pone.0022290","article-title":"Structural and functional profiling of the human histone methyltransferase smyd3","volume":"6","author":"Foreman","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.prp.2018.04.005_bib0135","first-page":"1435","article-title":"Adenovirus-mediated e2f-1 gene transfer augments gemcitabine-induced apoptosis in human colon cancer cells","volume":"61","author":"Lin","year":"2015","journal-title":"Clin. Lab."},{"issue":"22","key":"10.1016\/j.prp.2018.04.005_bib0140","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/jnci\/djt304","article-title":"Smyd3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription","volume":"105","author":"Liu","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.prp.2018.04.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170656","article-title":"Correlations of ezh2 and smyd3 gene polymorphisms with breast cancer susceptibility and prognosis","volume":"38","author":"Ma","year":"2018","journal-title":"Biosci. Rep."},{"issue":"Suppl.3","key":"10.1016\/j.prp.2018.04.005_bib0150","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jceh.2014.02.155","article-title":"Risk factors for hepatocellular carcinoma in india","volume":"4","author":"Kar","year":"2014","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2018.04.005_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2015.61.5724","article-title":"Infection and cancer: the case of hepatitis b","volume":"34","author":"Chan","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2018.04.005_bib0160","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.01261-15","article-title":"Hepatitis b virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.prp.2018.04.005_bib0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/apt.12207","article-title":"Meta-analysis: the association of hepatitis b virus genotypes and hepatocellular carcinoma","volume":"37","author":"Wong","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.prp.2018.04.005_bib0170","first-page":"34","article-title":"Management of liver cirrhosis in patients with hepatocellular carcinoma","volume":"2","author":"Ismail","year":"2013","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.04.005_bib0175","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1016\/j.cgh.2014.10.011","article-title":"Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants","volume":"992\u2013999","author":"Pais","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818300463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818300463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T11:54:54Z","timestamp":1534938894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818300463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0344033818300463"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.04.005","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SMYD3 VNTR 3\/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}